MX2009006529A - Formas cristalinas de ilaprazol solvatado. - Google Patents
Formas cristalinas de ilaprazol solvatado.Info
- Publication number
- MX2009006529A MX2009006529A MX2009006529A MX2009006529A MX2009006529A MX 2009006529 A MX2009006529 A MX 2009006529A MX 2009006529 A MX2009006529 A MX 2009006529A MX 2009006529 A MX2009006529 A MX 2009006529A MX 2009006529 A MX2009006529 A MX 2009006529A
- Authority
- MX
- Mexico
- Prior art keywords
- ilaprazole
- crystalline forms
- methyl
- relates
- gastric acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se refiere a formas cristalinas de varios solvatos de ilaprazol, 2[[(4-metoxi-3-metil-2-piridinil)-metil]sulfinil]-5- (1H-pirrol-1-il)-1H-bencimidazol. La invención se refiere también a una composición farmacéutica para inhibir la secreción de ácido gástrico, que comprende hidrato de ilaprazol cristalino de acuerdo con la invención, en una cantidad efectiva para inhibir la secreción de ácido gástrico, y un portador aceptable para uso farmacéutico. La invención provee también métodos de tratamiento para diversos trastornos gastrointestinales (GI) relacionados con el ácido.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87760806P | 2006-12-29 | 2006-12-29 | |
US88749907P | 2007-01-31 | 2007-01-31 | |
PCT/US2007/089137 WO2008083341A1 (en) | 2006-12-29 | 2007-12-28 | Crystalline forms of solvated ilaprazole |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009006529A true MX2009006529A (es) | 2009-08-18 |
Family
ID=39313094
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006530A MX2009006530A (es) | 2006-12-29 | 2007-12-28 | Formas de estado solido de ilaprazol racemico. |
MX2009006529A MX2009006529A (es) | 2006-12-29 | 2007-12-28 | Formas cristalinas de ilaprazol solvatado. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006530A MX2009006530A (es) | 2006-12-29 | 2007-12-28 | Formas de estado solido de ilaprazol racemico. |
Country Status (19)
Country | Link |
---|---|
US (4) | US7989632B2 (es) |
EP (2) | EP2102192B1 (es) |
JP (2) | JP5315254B2 (es) |
KR (3) | KR101052387B1 (es) |
CN (2) | CN101687849B (es) |
AU (2) | AU2007341992B2 (es) |
CA (2) | CA2674347C (es) |
DK (1) | DK2102192T3 (es) |
ES (1) | ES2398846T3 (es) |
HK (2) | HK1140483A1 (es) |
IL (2) | IL199234A (es) |
MX (2) | MX2009006530A (es) |
MY (2) | MY146462A (es) |
NO (2) | NO20092398L (es) |
NZ (2) | NZ577129A (es) |
PL (1) | PL2102192T3 (es) |
PT (1) | PT2102192E (es) |
RU (2) | RU2466129C2 (es) |
WO (2) | WO2008083333A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101144600B1 (ko) * | 2009-12-08 | 2012-05-16 | 일양약품주식회사 | 일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 |
CN103204843B (zh) * | 2012-01-13 | 2014-12-31 | 丽珠医药集团股份有限公司 | 结晶型艾普拉唑钠乙醇化物及其制备方法 |
CN103204842B (zh) * | 2012-01-13 | 2014-10-15 | 丽珠医药集团股份有限公司 | 结晶型艾普拉唑钠水合物及其制备方法 |
WO2013114232A1 (en) * | 2012-02-02 | 2013-08-08 | Lupin Limited | Process for preparation of crystalline form l of ilaprazole |
CN102746277B (zh) * | 2012-06-21 | 2014-05-14 | 丽珠医药集团股份有限公司 | 一种结晶形式的艾普拉唑钠及其制备方法 |
CN102746275B (zh) * | 2012-06-21 | 2014-07-16 | 丽珠医药集团股份有限公司 | 结晶型艾普拉唑钠及其制备方法 |
CN103172618B (zh) * | 2013-02-27 | 2014-09-03 | 丽珠医药集团股份有限公司 | 艾普拉唑晶型及其制备方法 |
CN104370886B (zh) * | 2014-11-18 | 2016-05-18 | 宁夏康亚药业有限公司 | 艾普拉唑晶型及其制备方法和应用 |
CN105055342A (zh) * | 2015-08-13 | 2015-11-18 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗消化性溃疡的药物艾普拉唑钠组合物冻干粉针剂 |
CN105055343A (zh) * | 2015-08-31 | 2015-11-18 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种治疗胃病的药物艾普拉唑钠组合物冻干粉针剂 |
CN106749191A (zh) * | 2016-12-10 | 2017-05-31 | 珠海保税区丽珠合成制药有限公司 | 艾普拉唑晶型ⅱ及其制备方法 |
KR101961028B1 (ko) * | 2017-10-12 | 2019-03-21 | 중앙대학교 산학협력단 | 일라프라졸을 유효성분으로 함유하는 급성 위염의 예방 또는 치료용 약학 조성물 |
KR102332996B1 (ko) * | 2020-04-13 | 2021-12-01 | 중앙대학교 산학협력단 | 일라프라졸을 유효성분으로 함유하는 장폐색증 예방 또는 치료용 약학조성물 |
KR20220065235A (ko) | 2020-11-13 | 2022-05-20 | 주식회사 파마코스텍 | 일라프라졸 혼형 결정의 신규한 제조방법 |
KR102250509B1 (ko) | 2020-12-09 | 2021-05-11 | 유니셀랩 주식회사 | 새로운 일라프라졸/자일리톨 공결정 |
KR20210019469A (ko) | 2021-02-02 | 2021-02-22 | 주식회사 파마코스텍 | 일라프라졸 나트륨 결정형 및 신규한 제조방법 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0179401B1 (ko) * | 1994-02-28 | 1999-03-20 | 송택선 | 신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체 |
US6331539B1 (en) | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
RU2232159C2 (ru) * | 1999-07-29 | 2004-07-10 | Регентский Совет Университета Калифорнии | Производные бензимидазола и фармацевтические композиции, содержащие пролекарство ингибитора протонного насоса |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
KR20040093187A (ko) | 2002-03-27 | 2004-11-04 | 테바 파마슈티컬 인더스트리즈 리미티드 | 란소프라졸 다형 및 그것의 제조 방법 |
CA2597632C (en) | 2005-03-25 | 2012-05-15 | Livzon Pharmaceutical Group Inc. | Substituted sulfoxide compounds, methods for preparing the same and use thereof |
WO2006118534A1 (en) * | 2005-05-04 | 2006-11-09 | Astrazeneca Ab | Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux |
-
2007
- 2007-12-28 MY MYPI20092733A patent/MY146462A/en unknown
- 2007-12-28 CN CN2007800488456A patent/CN101687849B/zh not_active Expired - Fee Related
- 2007-12-28 CA CA2674347A patent/CA2674347C/en active Active
- 2007-12-28 KR KR1020097013519A patent/KR101052387B1/ko active IP Right Grant
- 2007-12-28 PT PT78700911T patent/PT2102192E/pt unknown
- 2007-12-28 MY MYPI20092734A patent/MY145936A/en unknown
- 2007-12-28 JP JP2009544310A patent/JP5315254B2/ja not_active Expired - Fee Related
- 2007-12-28 MX MX2009006530A patent/MX2009006530A/es active IP Right Grant
- 2007-12-28 DK DK07870091.1T patent/DK2102192T3/da active
- 2007-12-28 US US11/966,896 patent/US7989632B2/en not_active Expired - Fee Related
- 2007-12-28 AU AU2007341992A patent/AU2007341992B2/en not_active Ceased
- 2007-12-28 JP JP2009544309A patent/JP5315253B2/ja active Active
- 2007-12-28 EP EP07870091A patent/EP2102192B1/en active Active
- 2007-12-28 EP EP07866107A patent/EP2102191B1/en active Active
- 2007-12-28 AU AU2007341984A patent/AU2007341984B2/en active Active
- 2007-12-28 ES ES07870091T patent/ES2398846T3/es active Active
- 2007-12-28 RU RU2009122241/04A patent/RU2466129C2/ru active
- 2007-12-28 NZ NZ577129A patent/NZ577129A/en unknown
- 2007-12-28 MX MX2009006529A patent/MX2009006529A/es active IP Right Grant
- 2007-12-28 RU RU2009122242/04A patent/RU2464270C2/ru not_active IP Right Cessation
- 2007-12-28 KR KR1020097013491A patent/KR20090086121A/ko not_active Application Discontinuation
- 2007-12-28 PL PL07870091T patent/PL2102192T3/pl unknown
- 2007-12-28 NZ NZ577509A patent/NZ577509A/en not_active IP Right Cessation
- 2007-12-28 WO PCT/US2007/089127 patent/WO2008083333A1/en active Application Filing
- 2007-12-28 KR KR1020117016139A patent/KR20110091594A/ko not_active Application Discontinuation
- 2007-12-28 CN CN2007800488403A patent/CN101687848B/zh active Active
- 2007-12-28 US US11/966,868 patent/US7999110B2/en active Active
- 2007-12-28 CA CA2674358A patent/CA2674358C/en not_active Expired - Fee Related
- 2007-12-28 WO PCT/US2007/089137 patent/WO2008083341A1/en active Application Filing
-
2009
- 2009-06-08 IL IL199234A patent/IL199234A/en active IP Right Grant
- 2009-06-08 IL IL199242A patent/IL199242A/en not_active IP Right Cessation
- 2009-06-24 NO NO20092398A patent/NO20092398L/no not_active Application Discontinuation
- 2009-06-29 NO NO20092464A patent/NO342530B1/no unknown
-
2010
- 2010-07-16 HK HK10106900.4A patent/HK1140483A1/xx not_active IP Right Cessation
- 2010-07-16 HK HK10106901.3A patent/HK1140484A1/xx unknown
- 2010-11-04 US US12/939,266 patent/US8592599B2/en not_active Expired - Fee Related
- 2010-11-04 US US12/939,276 patent/US8592600B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009006529A (es) | Formas cristalinas de ilaprazol solvatado. | |
IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
IL187236A0 (en) | Compositions and methods for inhibiting gastric acid secretion | |
UA89812C2 (ru) | Замещенные пиридинильные и пиримидинильные производные, которые применяют как модуляторы метаболизма и для лечения ассоциированных с ним расстройств | |
MX2012005358A (es) | Procedimiento para la preparacion de etexilato de dabigatran. | |
WO2009016462A3 (en) | Substituted bicyclolactam compounds | |
PL2019683T5 (pl) | Podawanie czynników wzrostu do leczenia zaburzeń OUN | |
WO2007134678A3 (de) | Triazolderivate ii | |
ZA200701629B (en) | Gyrase inhibitors and uses thereof | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
JO2645B1 (en) | Vehicles | |
MX2009004140A (es) | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa 3. | |
WO2009158431A3 (en) | Pyrimidine derivatives as kinase inhibitors | |
WO2008050199A3 (en) | Substituted phenylmethyl bicyclocarboxyamide compounds | |
MX2009000080A (es) | Derivados de bencimidazol como inhibidores selectivos de la bomba de acido. | |
HK1104035A1 (en) | Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same | |
PH12014500079A1 (en) | 6-substituted phenoxychroman carboxylic acid derivatives | |
WO2009011910A3 (en) | Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment | |
TW200600502A (en) | Novel 6-substituted benzimidazoles | |
WO2007138468A3 (en) | Processes for the preparation of lansoprazole | |
TW200720273A (en) | Pharmaceutically active spiro-benzimidazoles | |
ZA200903981B (en) | Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethyl-benzamide | |
WO2006067599A3 (en) | Stable oral benzimidazole compositions and process of preparation thereof | |
MXPA05009183A (es) | Polimorfos de s-omeprazol. | |
WO2008084067A3 (en) | Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |